Shiffman ML - Search Results

1

Alpha interferon combined with ribavirin potentiates proliferative suppression but not cytokine production in mitogenically stimulated human lymphocytes.

Shiffman ML, Verbeke SB, Kimball PM. Shiffman ML, et al. Antiviral Res. 2000 Nov;48(2):91-9. doi: 10.1016/s0166-3542(00)00120-0. Antiviral Res. 2000. PMID: 11114411

2

The impact of a positive crossmatch upon outcome after liver transplantation.

Goggins WC, Fisher RA, Kimball PM, Wolfe L, Hill BE, Pietruszka TD, Shiffman ML, Sanyal AJ, Luketic VA, Ham JM, Posner MP. Goggins WC, et al. Among authors: shiffman ml. Transplantation. 1996 Dec 27;62(12):1794-8. doi: 10.1097/00007890-199612270-00019. Transplantation. 1996. PMID: 8990365

3

Use of granulocyte macrophage colony stimulating factor alone or in combination with interferon-alpha-2b for treatment of chronic hepatitis C.

Shiffman ML, Hofmann CM, Luketic VA, Sanyal AJ. Shiffman ML, et al. J Hepatol. 1998 Mar;28(3):382-9. doi: 10.1016/s0168-8278(98)80310-3. J Hepatol. 1998. PMID: 9551674 Clinical Trial.

4

A prospective randomized trial of mycophenolate mofetil with neoral or tacrolimus after orthotopic liver transplantation.

Fisher RA, Ham JM, Marcos A, Shiffman ML, Luketic VA, Kimball PM, Sanyal AJ, Wolfe L, Chodorov A, Posner MP. Fisher RA, et al. Among authors: shiffman ml. Transplantation. 1998 Dec 27;66(12):1616-21. doi: 10.1097/00007890-199812270-00008. Transplantation. 1998. PMID: 9884248 Clinical Trial.

5

Use of high-dose interferon in the treatment of chronic hepatitis C.

Shiffman ML. Shiffman ML. Semin Liver Dis. 1999;19 Suppl 1:25-33. Semin Liver Dis. 1999. PMID: 10349690 Review.

6

Treatment of chronic hepatitis C in patients who failed interferon monotherapy: effects of higher doses of interferon and ribavirin combination therapy. The Virginia Cooperative Hepatitis Treatment Group.

Shiffman ML, Hofmann CM, Gabbay J, Luketic VA, Sterling RK, Sanyal AJ, Contos MJ, Ryan MJ, Yoshida C, Rustgi V. Shiffman ML, et al. Am J Gastroenterol. 2000 Oct;95(10):2928-35. doi: 10.1111/j.1572-0241.2000.02321.x. Am J Gastroenterol. 2000. PMID: 11051370 Clinical Trial.

7

A randomized, controlled trial to determine whether continued ribavirin monotherapy in hepatitis C virus-infected patients who responded to interferon-ribavirin combination therapy will enhance sustained virologic response.

Shiffman ML, Hofmann CM, Sterling RK, Luketic VA, Contos MJ, Sanyal AJ. Shiffman ML, et al. J Infect Dis. 2001 Aug 15;184(4):405-9. doi: 10.1086/322778. Epub 2001 Jul 16. J Infect Dis. 2001. PMID: 11471097 Clinical Trial.

8

Ethnicity and cytokine production gauge response of patients with hepatitis C to interferon-alpha therapy.

Kimball P, Elswick RK, Shiffman M. Kimball P, et al. J Med Virol. 2001 Nov;65(3):510-6. J Med Virol. 2001. PMID: 11596086 Clinical Trial.

9

Proliferative suppression and class I insufficiency on peripheral blood cells from hepatitis C patients overcome by exogenous cytokines or high-dose mitogen.

Kimball P, Verbeke S, Shiffman M. Kimball P, et al. Clin Immunol. 2002 Jun;103(3 Pt 1):317-23. doi: 10.1006/clim.2002.5217. Clin Immunol. 2002. PMID: 12173307

10

Comparison of 125I-interferon-alpha binding to peripheral blood cells from African-Americans and Caucasians with hepatitis C.

Kimball P, Verbeke S, Shiffman M. Kimball P, et al. J Viral Hepat. 2003 Sep;10(5):354-9. doi: 10.1046/j.1365-2893.2003.00444.x. J Viral Hepat. 2003. PMID: 12969187

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

360 results

Search Page

Filters